Print Email

Career Advising Program (CAP)

The Women & Medicine Commission’s Career Advising Program (CAP) is a longitudinal sponsorship initiative to help junior and mid-career women faculty successfully navigate academic advancement opportunities by connecting these members with senior “Career Sponsors” throughout SGIM (i.e., Associate or Full Professors). Sponsoring activities focus on CV preparation, targeted committee membership, and strategies for relationship-building for career advancement. 

Why is Sponsorship important?

Sponsorship is different from mentorship. Sponsorship focuses on promoting a more junior individual into leadership roles, high-impact committees, or other competitive opportunities. It requires the sponsor (advisor) to put their influence and credibility on the line for the person being sponsored (advisee) and can increase the advisee’s visibility and professional networks.

In other words, “A coach talks to you, a mentor talks with you, and a sponsor talks about you.”

Mission Statement: The Career Advising Program (CAP) is dedicated to promoting the advancement of women physicians by connecting them with dedicated sponsors who will promote their successes, expand their professional networks, and champion them among academic colleagues.

Target Sponsors (Advisors): All SGIM members who are Associate or Full Professors with an interest in the advancement of women in medicine. Someone with organizational or institutional influence who can advocate for a more junior colleague in career-advancing opportunities. 

Target Sponsees (Advisees): Women Associate or Assistant Professors, Instructors, and Fellows/Chief Residents interested in academic promotion or career advancement can benefit from more senior faculty members promoting them for career-advancing opportunities. Sponsees may also be referred to as proteges. 

Required Commitment is two years with at least bi-annual contact between sponsors (advisors) and sponsees (advisees) via email, phone, virtually, or in-person. The advisee must maintain SGIM membership during the duration of the program. Additionally, we expect advisor-advisee pairs to meet face-to-face (virtual or in-person) at least once during the two-year commitment. The Women & Medicine Commission hosts a reception for all CAP participants every year at SGIM’s Annual Meeting, and we hope our advisors and advisees can also connect then. To continue to improve the CAP program, we may reach out to you periodically after you complete the CAP program. Ap

Here is how CAP will ensure your relationship is successful:

  1. Communicating with advisees to facilitate maintaining relationships with their advisors through regular email or virtual contact. It is the advisee's responsibility to maintain this relationship. 
  2. Supporting advisors through regular follow-up to see how the advisor-advisee relationship is progressing. 

We are considering a model that pairs one sponsor (advisor) with up to two sponsees (advisee). This expands CAP’s capacity for matches and provides advisees with the opportunity to serve as near-peer sponsors.

The CAP Chair and the CAP Chair-Elect will create advisor-advisee matches based on application information. 

Important Dates 

January 15, 2024

Applications for Sponsors and Sponsees Open

March 22, 2024

Applications for Sponsors and Sponsees Close

March 22 - April 19, 2024

Sponsors and Sponsees Matching 

April 26, 2024 

Sponsors and Sponsees are Notified

CAP Leadership

Peter Cram, MD                        
University of Texas Medical Branch School of Medicine

Anthi Katsouli, MD, MPH
Loyola University Medical Center

Alia Chisty, MD
Penn State Hershey Medical Center

Are you interested in joining the CAP leadership team? Apply today to join the team!


Contact Jillian Gann at

SGIM continues its journey to becoming an anti-racist society that is committed to promoting and championing diversity, equity, and inclusion as a strategic priority. For all applications, we seek to ensure a diverse applicant pool that reflects our membership, and all applicants will be given equal consideration by a diverse panel of reviewers.